<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xmlns="http://www.sec.gov/edgar/rega/onezfiler">
  <headerData>
    <submissionType>1-Z</submissionType>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <filer>
        <issuerCredentials>
          <cik>0001723443</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>
      <flags>
        <confirmingCopyFlag>false</confirmingCopyFlag>
        <successorFilingFlag>N</successorFilingFlag>
        <returnCopyFlag>false</returnCopyFlag>
        <overrideInternetFlag>false</overrideInternetFlag>
      </flags>
    </filerInfo>
  </headerData>
  <formData>
    <item1>
      <issuerName>InSitu Biologics, Inc</issuerName>
      <street1>2155 Woodlane Drive, Suite 102</street1>
      <city>Woodbury</city>
      <stateOrCountry>MN</stateOrCountry>
      <zipCode>55125</zipCode>
      <phone>651-337-4799</phone>
      <commissionFileNumber>024-10845</commissionFileNumber>
    </item1>
    <summaryInfoOffering>
      <offeringQualificationDate>03-27-2019</offeringQualificationDate>
      <offeringCommenceDate>03-27-2019</offeringCommenceDate>
      <offeringSecuritiesQualifiedSold>10000010</offeringSecuritiesQualifiedSold>
      <offeringSecuritiesSold>3921998</offeringSecuritiesSold>
      <pricePerSecurity>5.7500</pricePerSecurity>
      <portionSecuritiesSoldIssuer>3921997.95</portionSecuritiesSoldIssuer>
      <portionSecuritiesSoldSecurityholders>0.00</portionSecuritiesSoldSecurityholders>
      <salesCommissionsSpName>SageWorks Capital</salesCommissionsSpName>
      <salesCommissionsSpName>LLC</salesCommissionsSpName>
      <salesCommissionsFee>36344.00</salesCommissionsFee>
      <auditorSpName>Baker Tilly US</auditorSpName>
      <auditorSpName>LLP</auditorSpName>
      <auditorFees>69018.00</auditorFees>
      <legalSpName>Trowbridge Sidoti LLP</legalSpName>
      <legalFees>54949.00</legalFees>
      <promoterSpName>FundAthena</promoterSpName>
      <promoterSpName>Inc.</promoterSpName>
      <promotersFees>110165.00</promotersFees>
      <crdNumberBrokerDealer>000162182</crdNumberBrokerDealer>
      <issuerNetProceeds>3651521.95</issuerNetProceeds>
    </summaryInfoOffering>
    <certificationSuspension>
      <securitiesClassTitle>Class A Common Stock</securitiesClassTitle>
      <certificationFileNumber>024-10845</certificationFileNumber>
      <approxRecordHolders>70</approxRecordHolders>
    </certificationSuspension>
    <signatureTab>
      <cik>0001723443</cik>
      <regulationIssuerName1>InSitu Biologics, Inc</regulationIssuerName1>
      <regulationIssuerName2>InSitu Biologics, Inc</regulationIssuerName2>
      <signatureBy>/s/ Kevin Bassett</signatureBy>
      <date>12-30-2020</date>
      <title>President and Chief Executive Officer</title>
    </signatureTab>
  </formData>
</edgarSubmission>
